Ipratropium Bromide Inhalation
Ipratropium Bromide Inhalation is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Ipratropium Bromide Inhalation; Generic name: IPRATROPIUM BROMIDE INHALATION; Manufacturer: Armstrong Pharmaceuticals, Inc..
| Brand name | Ipratropium Bromide Inhalation |
|---|---|
| Generic name | IPRATROPIUM BROMIDE INHALATION |
| Manufacturer | Armstrong Pharmaceuticals, Inc. |
| Used for | 1 INDICATIONS AND USAGE Ipratropium bromide HFA inhalation aerosol is indicated as a bronchodilator for maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. Ipratropium bromide HFA inhalation aerosol is an anticholinergic indicated for the maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema |
| Dosage | 2 DOSAGE AND ADMINISTRATION The usual starting dose of ipratropium bromide HFA inhalation aerosol is two inhalations four times a day. Patients may take additional inhalations as required; however, the total number of inhalations should not exceed 12 in 24 hours. Ipratropium bromide HFA inhalation aerosol is a solution aerosol that does not require shaking. However, as with any other metered-dose inhaler, some coordination is required between actuating the canister and inhaling the medication. P |
| Active ingredient(s) | IPRATROPIUM BROMIDE |
| Route | RESPIRATORY (INHALATION) |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=133cc2ed-f018-4295-b84e-b24382299360 |